NCT05981963View on ClinicalTrials.gov

A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 17, 2023

Primary Completion Date

October 22, 2023

Study Completion Date

October 22, 2023

Conditions
Healthy Male Volunteers
Interventions
DRUG

[14C]-BMS-986196

Specified dose on specified days

Trial Locations (1)

53704-2526

Labcorp Clinical Research Unit - Madison, Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05981963 - A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants | Biotech Hunter | Biotech Hunter